Exercise Training for Older Adults With Multiple Sclerosis
Trial Summary
What is the purpose of this trial?
The overall objective of the proposed randomized controlled (RCT) is to determine the feasibility and efficacy of a 16-week theory-based, remotely-delivered, combined exercise (aerobic and resistance) training intervention for improving cognitive and physical function in older adults (50+ years) with multiple sclerosis (MS) who have mild-to-moderate cognitive and walking impairment. Participants (N=50) will be randomly assigned into exercise training (combined aerobic and resistance exercise) condition or active control (flexibility and stretching) condition. The 16-week intervention will be delivered and monitored remotely within a participant's home/community and supported by Zoom-based chats guided by social cognitive theory (SCT) via a behavioral coach. Participants will receive training materials (e.g., prescriptive manual and exercise equipment), one-on-one coaching, action-planning via calendars, self-monitoring via logs, and SCT-based newsletters. It is hypothesized that the home-based exercise intervention will yield beneficial effects on cognition, mobility, physical activity, and vascular function compared with an active control condition (flexibility and stretching intervention), and these improvements will be sustained during a 16-week follow-up period.
Research Team
Peixuan Zheng, PhD
Principal Investigator
University of Illinois at Chicago
Eligibility Criteria
This trial is for adults aged 50 or older with Multiple Sclerosis who can walk (with or without help) and have mild-to-moderate cognitive impairment. They must have internet access, be able to visit the lab for tests, and not have had an MS relapse in the last month. People with other neurological conditions, cardiovascular diseases, or a high risk of injury from exercise cannot join.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Aerobic and Resistance Exercise Program (GEMS program)
- Flexibility and Stretching Program (FLEX-MS program)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor